QUEST DIAGNOSTICS INC's ticker is DGX and the CUSIP is 74834L100. A total of 24 filers reported holding QUEST DIAGNOSTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Riverwater Partners LLC | 6,676 | $920,522 | 0.73% |
| Somerset Trust Co | 9,665 | $1,332,610 | 0.58% |
| Pensionfund Sabic | 9,400 | $1,296 | 0.41% |
| Martin Capital Partners, LLC | 6,265 | $864 | 0.35% |
| First Financial Bank - Trust Division | 16,005 | $2,206,768 | 0.22% |
| IMPACTfolio, LLC | 1,708 | $235,499 | 0.15% |
| O'Keefe Stevens Advisory, Inc. | 2,500 | $344,700 | 0.14% |
| MASSMUTUAL TRUST CO FSB/ADV | 16,623 | $2,291,979 | 0.08% |
| Montecito Bank & Trust | 1,909 | $263,213 | 0.06% |
| OPTIMUM INVESTMENT ADVISORS | 600 | $82,728 | 0.04% |
| Czech National Bank | 19,692 | $2,715,133 | 0.04% |
| Symmetry Partners, LLC | 4,868 | $670 | 0.04% |
| M&R CAPITAL MANAGEMENT INC | 1,008 | $138,983 | 0.04% |
| DnB Asset Management AS | 37,101 | $5,115,486 | 0.03% |
| EXCHANGE TRADED CONCEPTS, LLC | 4,417 | $609,016 | 0.02% |
| Capital Investment Advisors, LLC | 4,694 | $647,185 | 0.02% |
| Pacifica Partners Inc. | 200 | $26,978 | 0.01% |
| Compass Wealth Management LLC | 295 | $40,675 | 0.01% |
| BALDWIN BROTHERS LLC/MA | 400 | $55,152 | 0.00% |
| Versant Capital Management, Inc | 45 | $6,205 | 0.00% |
About QUEST DIAGNOSTICS INC
Quest Diagnostics Inc. is a leading provider of diagnostic information services. The company offers a wide range of services, including clinical laboratory testing, diagnostic imaging, and information technology solutions. Quest Diagnostics operates in the United States, serving patients and healthcare providers across the country.
The company has a strong reputation for quality and accuracy, with a focus on providing timely and reliable results. Quest Diagnostics has a team of highly trained professionals who use the latest technology and techniques to deliver accurate and actionable information to patients and healthcare providers.
Quest Diagnostics has a strong financial position, with a solid balance sheet and a history of consistent growth. The company has a market capitalization of over $15 billion and generates annual revenues of more than $7 billion.
Quest Diagnostics is led by a team of experienced executives, including CEO Steve Rusckowski and CFO Mark Guinan. The company has a strong commitment to innovation and is constantly exploring new ways to improve its services and expand its offerings.
Overall, Quest Diagnostics is a well-respected and successful company that is poised for continued growth and success in the years ahead. With a focus on quality, accuracy, and innovation, Quest Diagnostics is a leader in the diagnostic information services industry and a valuable partner for patients and healthcare providers alike.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
External links
This page lists QUEST DIAGNOSTICS INC's shareholders in Q4 2023. To view QUEST DIAGNOSTICS INC's shareholder history, click here.